When determining the prognosis in patients undergoing hematopoietic stem cell transplantation (HSCT) for myelodysplastic syndrome (MDS) which risk factors receive 1 point?

Updated: Jul 24, 2018
  • Author: Emmanuel C Besa, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print

Shaffer and colleagues developed a system that can be used to determine prognosis in patients undergoing HLA-matched and -mismatched allogeneic HSCT for MDS. [36] In the system, the following risk factors are assigned 1 point:

  • Blood blasts >3%
  • Platelet count ≤50 × 10 9/L at transplantation
  • Karnofsky performance status < 90%
  • Comprehensive cytogenetic risk score of poor or very poor
  • Age 30 to 49 years

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!